Duchenne Muscular Dystrophy PBMC

Duchenne Muscular Dystrophy PBMC for Neuromuscular and Gene Therapy Research

Duchenne Muscular Dystrophy PBMC products are sourced from IRB-consented donors clinically diagnosed with Duchenne muscular dystrophy (DMD) and processed within 24 hours of collection under standardized SOPs. These cryopreserved peripheral blood mononuclear cells are stored in CryoStor® CS10 and shipped on dry ice. Research Use Only (RUO).

Disease Basis and Why PBMC

  • DMD is an X-linked recessive monogenic disease caused by mutations in the DMD gene that abolish functional dystrophin, leaving the muscle sarcolemma mechanically fragile and prone to contraction-induced damage.
  • Repeated muscle fiber injury provokes a chronic inflammatory response, with immune cell infiltration of dystrophic muscle contributing to degeneration, impaired regeneration, and fibro-adipose replacement.
  • Corticosteroids remain a standard of care precisely because dampening this inflammatory component modifies disease course, which makes circulating immune cells a legitimate object of study.
  • PBMCs are central to gene therapy development in DMD: T cell responses to AAV capsid and to transgene-derived dystrophin epitopes are a recognized safety and durability consideration, and are commonly assessed by ex vivo assays such as ELISpot and intracellular cytokine staining.
  • Donor PBMCs also provide a genomic DNA source for mutation confirmation and a starting material for reprogramming and cell model generation.
  • Unlike plasma or serum, PBMCs support live-cell immunophenotyping, antigen-specific stimulation, and single-cell transcriptomics from genotype-annotated donors.

Donor Stratification Available

  • DMD mutation type where documented: deletion, duplication, nonsense, or exon-skip amenable
  • Age band and ambulatory status (ambulatory versus non-ambulatory)
  • Corticosteroid therapy status and duration
  • Disease-modifying therapy: exon-skipping antisense oligonucleotide, gene therapy, or treatment-naive
  • Documented cardiac and respiratory involvement
  • Sex and self-reported race/ethnicity; Becker muscular dystrophy donors available on request
  • Matched healthy controls available

Product Features

  • Research Use Only (RUO), cryopreserved PBMCs
  • Clinically confirmed DMD donors
  • Processed within 24 hours of collection
  • Stored using CryoStor® CS10 freezing media
  • Custom aliquots available; shipped on dry ice
  • IRB-approved protocols and electronic informed consent, with parental or guardian permission for minors
  • Screen LeukoLot™ available prior to bulk orders

De-identified Donor Data

  • Verified DMD diagnosis
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Self-reported allergies and infectious disease history
  • Genotype, ambulatory status, and treatment history where available
  • Additional DMD-specific data available upon request

Applications

  • T cell response assays against AAV capsid and transgene-derived epitopes
  • Immunophenotyping of T cell, B cell, monocyte, and NK compartments
  • Ex vivo stimulation and cytokine release profiling
  • Bulk and single-cell transcriptomic analysis
  • Monocyte and macrophage polarization studies relevant to muscle inflammation and fibrosis
  • Genomic DNA extraction for mutation confirmation and genotype-phenotype work
  • Starting material for iPSC reprogramming and disease modeling
  • Immunomodulatory drug screening and mechanism-of-action studies

Other Duchenne Muscular Dystrophy Specimen Types

Compliance and Quality Assurance

  • IRB-approved collections and protocols
  • 21 CFR Part 11-compliant e-consent system
  • HIPAA-compliant donor data protection

Ordering & Customization

Duchenne Muscular Dystrophy PBMC samples are shipped on dry ice and available in custom aliquots. For pricing, availability, international orders, or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs. To browse all donor cohorts and current stock, visit our human PBMCs page.

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Frequently Asked Questions

Showing 1–12 of 30 results

Are samples IRB approved?

1 Answer

YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.

YES – all our products are research use only (RUO).

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

YES – Unique donors can be specified and guaranteed based on your requirements.

For information about sample quality, please see: Quality and Compliance

YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

1
×

Ask a Question

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information